Successful outcome of mismatched hematopoietic stem cell transplantation from a related donor in an infant with acute lymphoblastic leukemia and 9;11 translocation: Case report and review of the literature

International Journal of Hematology

Volumn 81, Issue 5, 2005, Pages 428-432

  Kitazawa, Junichi ^a,f   Tono, Chikako ^a   Terui, Kiminori ^a   Kinukawa, Naoko ^b   Oda, Megumi ^c   Isoyama, Keiichi ^d   Ishii, Eiichi ^e   Ito, Etsuro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^e SAGA UNIVERSITY   (Japan)

^f Kuroishi City Hospital   (Japan)

Author keywords

Bone marrow transplantation; Hetero to homo transplantation; Infant acute lymphoblastic leukemia; MLL gene rearrangement; t(9; 11)(p22; q23)

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 9; CYTOGENETICS; FEMALE; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; KARYOTYPE; MLL GENE; PROGNOSIS; RELAPSE; REMISSION; REVIEW; TREATMENT OUTCOME;

CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 9; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; INFANT; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROGNOSIS; PROTO-ONCOGENES; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 21444441231     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04156     Document Type: Review

References (26)

1. Pui CH, Ribeiro RC. International collaboration on childhood leukemia. Int J Hematol. 2003;78:383-389.
2. Kitazawa J, Ito E, Arai K, et al. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Med Pediatr Oncol. 2001;37:153-154.
3. Horibe K, Hara J, Yagi K, et al. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study. Int J Hematol. 2000;72:61-68.
4. Lorenzana AN, Rubin CM, Le Beau MM, et al. Immunoglobulin gene rearrangements in acute lymphoblastic leukemia with the 9;11 translocation. Genes Chromosomes Cancer. 1991;3:74-77.
5. Seeker-Walker LM on behalf of the European 11q23 Workshop participants. General report on the European Union concerted action workshop on 11q23, London, UK, May 1997. Leukemia. 1998;12:776-778.
6. Heerema NA, Arthur DC, Sather H, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome-a report of the Children's Cancer Group. Blood. 1994;83: 2274-2284.
7. Pui CH, Gayton PS, Boyett JM, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet. 2002;359:1909-1915.
8. Bennet JM, Catovsky D, Daniel MT, et al. Proposal for the classification of the acute leukemia. Br J Hematol. 1976;33:451-458.
9. Isoyama K, Eguchi M, Hibi S, et al. Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukemia Study (MLL96). Br J Haematol. 2002;118:999-1010.
10. Seeger K, Adams HP, Buchwald D, et al. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin Frankfurt Munster Study Group. Blood. 1998;91:1716-1722.
11. Behm FG, Raimondi SC, Frestedt JL, et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood. 1996;87: 2870-2877.
12. Swanbury GJ, Slater R, Bain BJ, et al. Hematological malignancies with t(9;11)(p21-22;q23): a laboratory and clinical study of 125 cases. Leukemia. 1998;12:792-800.
13. Kaneko Y, Shikano T, Maseki N, et al. Clinical characteristics of infant acute leukemia with or without 11q23 translocation. Leukemia. 1988;2:672-676.
14. Pui CH, Raimondi SC, Murphy SB, et al. An analysis of leukemic cell chromosomal features in infants. Blood. 1987;69:1289-1293.
15. Super HG, Strissel PL, Sobulo OM, et al. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes Cancer. 1997;20:185-195.
16. Chessells JM, Eden OB, Bailey CC, et al. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials-report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia. 1994;8:1275-1279.
17. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339:605-615.
18. Ishii E, Okamura J, Tsuchida M, et al. Infant leukemia in Japan: clinical and biological analysis of 48 cases. Med Pediatr Oncol. 1991;19:28-32.
19. Cimio G, Moir DT, Canaani O, et al. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res. 1991;51:6712-6714.
20. Ishii E, Kawasaki H, Isoyama K,et al. Recent advances in the treatment of infant acute myeloid leukemia. Leuk Lymphoma. 2003;44: 741-748.
21. Martinez-Climent JA, Espinosa R 3d, Thirman MJ, et al. Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias: identification of the t(9;11) as an indicator of long survival. J Pediatr Hematol Oncol. 1995;17:277-283.
22. Kawasaki H, Isoyama K, Eguchi M, et al. Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Blood. 2001;98: 3589-3594.
23. Kosaka K, Koh K, Kinukawa N, et al. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood. 2004;104:3527-3534.
24. Sanders JE, Im HJ, Hoffmeister PA, et al. Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood [Epub ahead of print]. January 6, 2005.
25. Japanese Society of Pediatric Hematology Hematopoietic Stem-Cell Transplantation Committee. National registry of hematopoietic stem-cell transplantation in children: 1998. Jpn J Pediatr Hematol. 2000;14:317-327.
26. Okada H, Nomi K, Hamatani S, et al. Induction of graft-versus-host disease and a graft-versus-leukemia effect using ubenimex in a patient with infantile leukemia relapsing after an unrelated cord blood transplant. Bone Marrow Transplant. 2002;30:463-465.